epocrates logo
epocrates logo
epocrates logo
  • 0

Diseases

Evaluation of palpitations

OVERVIEW

  • Summary
  • Urgent Considerations
  • Etiology

DIAGNOSIS

  • Differential Diagnosis
  • Diagnostic Approach

IMAGES

  • Library

REFERENCES

  • Citations
  • Credits

Summary

AAFont SizeShareMore Information
Palpitations are defined as the abnormal awareness of one's own heartbeat. It is a common complaint seen in the outpatient setting in virtually all age groups and demographics. Most palpitations are due to nonarrhythmic etiologies that occur during normal sinus rhythm.
A significant proportion of palpitations are due to non-life-threatening, treatable cardiac conditions. They include premature ventricular contractions, premature atrial contractions, and supraventricular tachycardias such as atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia, atrial tachycardia, and atrioventricular reentry tachycardia or Wolff-Parkinson-White syndrome. Ironically, the most common rhythm seen when evaluating patients for palpitations is sinus rhythm. A heightened sense of normal rhythm can be seen in settings of emotional or physical stress, or in conjunction with use of caffeine, alcohol, or other stimulants.
However, palpitations are occasionally a manifestation of potentially life-threatening conditions, especially in the setting of structural heart disease - for example, ventricular tachycardia (VT), which may lead to sudden cardiac death. Inherited conditions such as hypertrophic cardiomyopathy, Brugada syndrome, and long QT syndrome may also initially present with palpitations and carry a risk of sudden cardiac death.[1] [2]​
Palpitations associated with syncope are particularly worrying as they are more likely to be associated with malignant arrhythmias such as ventricular tachycardia and should also be urgently evaluated.
The evaluation of palpitations includes a careful and directed history and physical exam and a 12-lead ECG. Further testing and treatment should be guided by this initial evaluation, and includes ambulatory electrocardiographic monitoring and electrophysiologic testing.
content by BMJ Group
Last updated

Library

  • Wolff-Parkinson-White syndrome

    Wolff-Parkinson-White syndrome

  • Long QT syndrome

    Long QT syndrome

  • Hypertrophic cardiomyopathy

    Hypertrophic cardiomyopathy

  • Left ventricular hypertrophy and left atrial abnormality

    Left ventricular hypertrophy and left atrial abnormality

  • Inferior Q waves due to prior MI

    Inferior Q waves due to prior MI

  • Brugada syndrome ECG

    Brugada syndrome ECG

  • Atrioventricular nodal reentry tachycardia with pseudo-S waves

    Atrioventricular nodal reentry tachycardia with pseudo-S waves

Citations

    Key Articles

    • Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156.[Abstract][Full Text]

    • Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016 Apr 5;133(14):e506-74.[Abstract][Full Text]

    • Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018 Sep 25;138(13):e272-391.[Abstract][Full Text]

    • National Institute for Health and Care Excellence. Atrial fibrillation: diagnosis and management. Jun 2021 [internet publication].[Full Text]

    Referenced Articles

    • 1. Zimetbaum P, Josephson ME. Evaluation of patients with palpitations. N Engl J Med. 1998 May 7;338(19):1369-73[Abstract]

    • 2. Mellor GJ, Behr ER. Cardiac channelopathies: diagnosis and contemporary management. Heart. 2021 Jun 11;107(13):1092-9.

    • 3. Wilken J. Evidence-based recommendations for the evaluation of palpitations in the primary care setting. Med Clin North Am. 2016 Sep;100(5):981-9.[Abstract]

    • 4. Mayou R, Bryant B, Forfar C, et al. Non-cardiac chest pain and benign palpitations in the cardiac clinic. Br Heart J. 1994 Dec;72(6):548-53.[Abstract][Full Text]

    • 5. Jonsbu E, Dammen T, Morken G, et al. Patients with noncardiac chest pain and benign palpitations referred for cardiac outpatient investigation: a 6-month follow-up. Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):406-12.[Abstract]

    • 6. Raviele A, Giada F, Bergfeldt L, et al. Management of patients with palpitations: a position paper from the European Heart Rhythm Association. Europace. 2011 Jul;13(7):920-34.[Abstract][Full Text]

    • 7. Barsky AJ, Cleary PD, Coeytaux RR, et al. Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Intern Med. 1994 Jun;9(6):306-13.[Abstract]

    • 8. Gillespie HS, Lin CC, Prutkin JM. Arrhythmias in structural heart disease. Curr Cardiol Rep. 2014 Aug;16(8):510.[Abstract]

    • 9. Gale CP, Camm AJ. Assessment of palpitations. BMJ. 2016 Jan 6;352:h5649.

    • 10. Barsky AJ, Cleary PD, Sarnie MK, et al. Panic disorder, palpitations, and the awareness of cardiac activity. J Nerv Ment Dis. 1994 Feb;182(2):63-71.[Abstract]

    • 11. Barsky AJ, Cleary PD, Coeytaux RR, et al. The clinical course of palpitations in medical outpatients. Arch Intern Med. 1995 Sep 11;155(16):1782-8.[Abstract]

    • 12. Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med. 1996 Feb;100(2):138-48.[Abstract]

    • 13. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156.[Abstract][Full Text]

    • 14. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.[Full Text]

    • 15. Riley AB, Manning WJ. Atrial fibrillation: an epidemic in the elderly. Expert Rev Cardiovasc Ther. 2011 Aug;9(8):1081-90.[Abstract]

    • 16. Samim D, Choffat D, Vollenweider P, et al. Prevalence of atrial fibrillation : the Swiss population-based CoLaus|PsyCoLaus study. Herz. 2023 Feb;48(1):48-54.[Abstract][Full Text]

    • 17. Go AS. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005 Mar-Apr;14(2):56-61.[Abstract]

    • 18. Marott JL, Skielboe AK, Dixen U, et al. Increasing population height and risk of incident atrial fibrillation: the Copenhagen City Heart Study. Eur Heart J. 2018 Dec 1;39(45):4012-9.[Abstract][Full Text]

    • 19. Crump C, Sundquist J, Winkleby MA, et al. Height, weight, and aerobic fitness level in relation to the risk of atrial fibrillation. Am J Epidemiol. 2018 Mar 1;187(3):417-26.[Abstract][Full Text]

    • 20. Turagam MK, Velagapudi P, Kocheril AG. Atrial fibrillation in athletes. Am J Cardiol. 2012 Jan 15;109(2):296-302.[Abstract]

    • 21. Parisi EJ, Chung EH. Palpitations in athletes: diagnosis, workup and treatment. Heart. 2023 Aug 10 [Epub ahead of print].[Abstract]

    • 22. Goyal R, Zivin A, Souza J, et al. Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J. 1996 Oct;132(4):765-7.[Abstract]

    • 23. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016 Apr 5;133(14):e506-74.[Abstract][Full Text]

    • 24. Lu CW, Wu MH, Chen HC, et al. Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation. Int J Cardiol. 2014 Jul 1;174(3):530-4.[Abstract]

    • 25. Wolfe RR, Driscoll DJ, Gersony WM, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect: results of 24-hour ECG monitoring. Circulation. 1993 Feb;87(2 Suppl):I89-101.[Abstract]

    • 26. Pedersen OD, Bagger H, Køber L, et al. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction. Int J Cardiol. 2005 Apr 8;100(1):65-71.[Abstract]

    • 27. Diamant MJ, Andrade JG, Virani SA, et al. Heart failure and atrial flutter: a systematic review of current knowledge and practices. ESC Heart Fail. 2021 Dec;8(6):4484-96.[Abstract][Full Text]

    • 28. Ebert M, Richter S, Dinov B, et al. Evaluation and management of ventricular tachycardia in patients with dilated cardiomyopathy. Heart Rhythm. 2019 Apr;16(4):624-31.[Abstract]

    • 29. Lukas Laws J, Lancaster MC, Ben Shoemaker M, et al. Arrhythmias as presentation of genetic cardiomyopathy. Circ Res. 2022 May 27;130(11):1698-722.[Abstract][Full Text]

    • 30. Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2020 Dec 22;76(25):3022-55.[Abstract][Full Text]

    • 31. Sen-Chowdhry S, Lowe MD, Sporton SC, et al. Arrhythmogenic right ventricular cardiomyopathy: Clinical presentation, diagnosis, and management. Am J Med. 2004 Nov 1;117(9):685-95.[Abstract]

    • 32. Haugaa KH, Haland TF, Leren IS, et al. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis. Europace. 2016 Jul;18(7):965-72.[Abstract][Full Text]

    • 33. Josephson ME, Wellens HJ. Differential diagnosis of supraventricular tachycardia. Cardiol Clin. 1990 Aug;8(3):411-42.[Abstract]

    • 34. La Vecchia L, Ometto R, Centofante P, et al. Arrhythmic profile, ventricular function, and histomorphometric findings in patients with idiopathic ventricular tachycardia and mitral valve prolapse: clinical and prognostic evaluation. Clin Cardiol. 1998 Oct;21(10):731-5.[Abstract]

    • 35. Hodzic E. Assessment of rhythm disorders in classical and nonclassical mitral valve prolapse. Med Arch. 2018 Feb;72(1):9-12.[Abstract][Full Text]

    • 36. Kubala M, Essayagh B, Michelena HI, et al. Arrhythmic mitral valve prolapse in 2023: evidence-based update. Front Cardiovasc Med. 2023 Apr 18:10:1130174.[Abstract][Full Text]

    • 37. Possner M, Gensini FJ, Mauchley DC, et al. Ebstein's anomaly of the tricuspid valve: an overview of pathology and management. Curr Cardiol Rep. 2020 Oct 9;22(12):157.[Abstract]

    • 38. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000 Sep 16;356(9234):975-81.[Abstract]

    • 39. Moe TG, Abrich VA, Rhee EK. Atrial fibrillation in patients with congenital heart disease. J Atr Fibrillation. 2017 Jun 30;10(1):1612.[Abstract][Full Text]

    • 40. Imazio M, Lazaros G, Picardi E, et al. Incidence and prognostic significance of new onset atrial fibrillation/flutter in acute pericarditis. Heart. 2015 Sep;101(18):1463-7.[Abstract]

    • 41. Hassanabad AF, Deniset JF, Fedak PWM. Pericardial inflammatory mediators that can drive postoperative atrial fibrillation in cardiac surgery patients. Can J Cardiol. 2023 Aug;39(8):1090-102.[Abstract]

    • 42. Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019 Aug 8;381(6):552-65.[Abstract]

    • 43. Csengeri D, Sprünker NA, Di Castelnuovo A, et al. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes. Eur Heart J. 2021 Mar 21;42(12):1170-7.[Abstract][Full Text]

    • 44. Tisdale JE, Chung MK, Campbell KB, et al. Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation. 2020 Oct 13;142(15):e214-33.[Abstract][Full Text]

    • 45. ​Medicines and Healthcare products Regulatory Agency. Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors. Jan 2024 [internet publication].[Full Text]

    • 46. Lombardi M, Carbone S, Del Buono MG, et al. Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e69-70.[Full Text]

    • 47. Gencer B, Djousse L, Al-Ramady OT, et al. Effect of long-term marine ɷ-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021 Dec 21;144(25):1981-90.[Abstract][Full Text]

    • 48. Kim EJ, Hoffmann TJ, Nah G, et al. Coffee consumption and incident tachyarrhythmias: reported behavior, mendelian randomization, and their interactions. JAMA Intern Med. 2021 Sep 1;181(9):1185-93.[Abstract][Full Text]

    • 49. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018 Sep 25;138(13):e272-391.[Abstract][Full Text]

    • 50. Varma N, Josephson ME. Therapy of "idiopathic" ventricular tachycardia. J Cardiovasc Electrophysiol. 1997 Jan;8(1):104-16.[Abstract]

    • 51. Coumel P. Clinical approach to paroxysmal atrial fibrillation. Clin Cardiol. 1990 Mar;13(3):209-12.[Abstract]

    • 52. Vikman S, Lindgren K, Mäkikallio TH, et al. Heart rate turbulence after atrial premature beats before spontaneous onset of atrial fibrillation. J Am Coll Cardiol. 2005 Jan 18;45(2):278-84.[Abstract]

    • 53. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002 Jun 11;105(23):2753-9.[Abstract]

    • 54. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006 Apr 15;173(8):910-6.[Abstract]

    • 55. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001 Jan 2;103(1):89-95.[Abstract][Full Text]

    • 56. Stimpel M, Wambach G. [Plasma levels of atrial natriuretic peptide (ANP) in patients with paroxysmal supraventricular tachycardia and concomitant polyuria (urina spastica)]. [in ger]. Z Kardiol. 1988;77 Suppl 2:124-9.[Abstract]

    • 57. Oliver JR, Twidale N, Lakin C, et al. Plasma atrial natriuretic polypeptide concentrations during and after reversion of paroxysmal supraventricular tachycardias. Br Heart J. 1988 Apr;59(4):458-62.[Abstract]

    • 58. Brugada P, Gursoy S, Brugada J, et al. Investigation of palpitations. Lancet. 1993 May 15;341(8855):1254-8.[Abstract]

    • 59. Thavendiranathan P, Bagai A, Khoo C, et al. Does this patient with palpitations have a cardiac arrhythmia? JAMA. 2009 Nov 18;302(19):2135-43.[Abstract]

    • 60. Hoefman E, Boer KR, van Weert HC, et al. Continuous event recorders did not affect anxiety or quality of life in patients with palpitations. J Clin Epidemiol. 2007 Oct;60(10):1060-6.[Abstract]

    • 61. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008 Sep 30;118(14):1497-1518.[Abstract][Full Text]

    • 62. National Institute for Health and Care Excellence. Atrial fibrillation: diagnosis and management. Jun 2021 [internet publication].[Full Text]

    • 63. Agency for Healthcare Research and Quality. Remote cardiac monitoring. December 2007 [internet publication].[Full Text]

    • 64. Kinlay S, Leitch JW, Neil A, et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations: a controlled clinical trial. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):16-20.[Abstract]

    • 65. Fogel RI, Evans JJ, Prystowsky EN. Utility and cost of event recorders in the diagnosis of palpitations, presyncope, and syncope. Am J Cardiol. 1997 Jan 15;79(2):207-8.[Abstract]

    • 66. Zimetbaum PJ, Kim KY, Josephson ME, et al. Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations: a cost-effectiveness analysis. Ann Intern Med. 1998 Jun 1;128(11):890-5.[Abstract]

    • 67. Rothman SA, Laughlin JC, Seltzer J, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007 Mar;18(3):241-7.[Abstract]

    • 68. Svennberg E, Tjong F, Goette A, et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace. 2022 Jul 15;24(6):979-1005.[Full Text]

    • 69. Narasimha D, Hanna N, Beck H, et al. Validation of a smartphone-based event recorder for arrhythmia detection. Pacing Clin Electrophysiol. 2018 Mar 1 [Epub ahead of print].[Abstract]

    • 70. National Institute for Health and Care Excellence. Heart valve disease presenting in adults: investigation and management. Nov 2021 [internet publication].[Full Text]

Have feedback?
Tell us about your experience
Scroll to Top
epocrates logo

Sign in to access our clinical decision support tools

Sign inCreate Account
Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information